TAK R&D Expense Growth
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) · R&D Expense Growth
TAK R&D Expense Growth
Latest reported-1.85%period ending
TAK FY R&D Growth (YoY) (0.00% → -1.85%)
Latest values, visible window
High-resolution chart · PNG
TAK r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -1.8541% | |
| 0.0415% | |
| 15.2527% | |
| 20.3841% | |
| 15.4122% | |
| -7.4227% | |
| 33.6909% | |
| 13.1689% | |
| 4.2068% | |
| -9.72% | |
| -9.4659% | |
| 11.8679% | |
| 5.3248% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |